AKB-57

AKB-57 is classified as Cannabinoid receptor agonist (likely CB1/CB2 agonism; exact efficacy/potency unknown). It belongs to the Indazole-3-carboxamide synthetic cannabinoid (presumed; name used on market does not uniquely define a structure) chemical class.

Also known as: APINAC, adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate

Classification

Chemical: Cannabinoid
Chemical: Synthetic cannabinoid

Effects

Rapid Intoxication Stoned Body High
Sedation
Nausea
Vomiting
Incoordination
Dry Mouth
Time Dilation
Memory Impairment
Anxiety
Panic
Paranoia
Irritability

Routes of Administration

Smoked

Dosage

Heavy: >5 mg
Light: 0.5 – 1.5 mg
Common: 1.5 – 3 mg
Strong: 3 – 5 mg
Threshold: <0.5 mg

Duration

Onset: 0.25-1.5 h
Peak: 0.08-0.5 h
Offset: 0.5-1.5 h
After Effects: 1.5-6 h
Total Duration: 1-2 h

Oral

Dosage

Heavy: >6 mg
Light: 1 – 2 mg
Common: 2 – 4 mg
Strong: 4 – 6 mg
Threshold: 0.5 mg

Duration

Onset: 0.5-1.5 h
Peak: 1-2 h
Offset: 2-6 h
After Effects: 4-24 h
Total Duration: 3-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

No external data sources listed for this substance yet.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu